Sourasky Medical Center (Ichilov)
Sourasky Medical Center (Ichilov)
Israel, Telavive
Pelles Sharon
23 tahun pengalaman
Klinik telah bersertifikat :
| Israel | Turki | Austria | |
| Pengangkatan kanker usus besar | dari $22,500 | dari $14,400 | dari $20,000 |
| Reseksi rektum | dari $24,500 | dari $10,250 | dari $21,000 |
| Kolektomi (reseksi usus besar) | dari $20,500 | dari $6,912 | dari $22,000 |
| Mesorektumektomi total secara robotik | - | dari $14,500 | - |
| Laparoskopi mesorektumrektomi | - | dari $9,500 | - |
Bookimed tidak menambah biaya tambahan dalam harga Pengangkatan kanker usus besar. Tarif berasal dari daftar harga resmi klinik. Anda membayar langsung di klinik untuk Pengangkatan kanker usus besar Anda saat tiba.
Bookimed berkomitmen pada keselamatan Anda. Kami hanya bekerja dengan institusi medis yang menjaga standar internasional tinggi dalam Pengangkatan kanker usus besar dan memiliki izin yang dibutuhkan untuk melayani pasien internasional di seluruh dunia.
Bookimed menawarkan bantuan ahli gratis. Koordinator medis pribadi mendukung Anda sebelum, selama, dan setelah perawatan, menyelesaikan semua masalah Anda. Anda tidak pernah sendirian dalam perjalanan Pengangkatan kanker usus besar Anda.
Pakar terkemuka dalam onkologi sarkoma dan tulang di Pusat Medis Sourasky dengan lebih dari 25 tahun pengalaman khusus.
Dr. Pelles Sharon berspesialisasi dalam pengobatan kanker usus besar di Sourasky Medical Center, menggabungkan keahlian bedah dengan teknik canggih seperti HIPEC dan imunoterapi.
Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.
He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.
He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.
Dr. Almog Ben-Yaacov is an Attending Surgeon in the Department of General and Oncological Surgery (Surgery C) at Sheba Medical Center. He specializes in cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC). His clinical focus includes gastric cancer, sarcoma, and complex colorectal malignancies. Since 2018, he has performed more than 200 HIPEC procedures.
MD, Semmelweis University, 2006, with honors. Training in cardiothoracic surgery at Sheba Medical Center. Residency in general surgery at Montefiore (Albert Einstein) and at Rabin (Beilinson). Board-certified in General Surgery and in Surgical Oncology.
Advanced training includes ESSO-certified HIPEC in Hamburg. Microwave liver ablation in Reims. NanoKnife at King’s College London. Advanced surgical oncology at Memorial Sloan Kettering (2019). His publications cover CRS+HIPEC outcomes and Hartmann’s reversal.